Umbrage, a Houston-based developer of enterprise software, has been acquired. Photo via umbrage.com

A Houston software company is celebrating an exit this month.

Umbrage, founded in 2019, is proving once again that Space City is a software hub. Earlier this month, Founder Will Womble announced that Umbrage has been acquired by Bain & Company.

Umbrage creates custom software for companies by partnering with an internal technology team that makes the products. It’s a “teach a man to fish” method that has brought the company great success in creating software such as Shell’s TapUp app.

Bain & Company works with clients in 64 cities across 39 countries, meaning the global consultancy is positioned to bring Umbrage worldwide.

"Alongside Bain, we can deliver enhanced end-to-end solutions that will position our clients for success and to adapt during waves of disruptive emerging technologies," says CEO Womble in the release.

Bain’s Vector program has advised more than 6,700 digital projects around the world and across industries. It works by creating joint teams featuring Bain’s consulting staff, allowing companies to reach their digital goals themselves, but with a little help, not unlike Umbrage’s own methods. Acquiring Umbrage gives Bain a boost in its ability to help clients on a larger scale.

"Bain's commitment to delivering results with clients requires expanding and enhancing its ability to innovate and industrialize digital solutions," says Arpan Sheth, global leader of Vector, Bain's digital delivery platform. "Joining forces with Umbrage will allow us to develop a best-in-class, craft-centric digital product and venture building studio that will enable our clients to not only develop successful digital strategies, but to also execute on these strategies through world-class software capabilities. Umbrage further enhances Bain's Next solution to support our clients in their business building missions.”

Once the deal is completed, Umbrage will operate independently, but as a branded service line that’s part of Bain Innovation & Design. But existing clients needn’t worry. Umbrage will continue to assist them, including clients in financial services, energy, natural resources, and other industries.

In 2021, Umbrage raised a $2 million round led by Rice Investment Group. Womble previously joined the Houston Innovators Podcast to share how Houston has played a role in the company's growth.

Will Womble founded Umbrage in 2018. Photo courtesy

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

TMC launches new biotech partnership with Republic of Korea

international collaboration

Houston's Texas Medical Center has launched its new TMC Republic of Korea BioBridge.

The new partnership brings together the TMC with the Osong Medical Innovation Foundation, or KBIOHealth. The Biobridge aims to support the commercialization of Korean biotech and life science startups in the U.S., foster clinical research, and boost collaboration in the public, private and academic sectors.

Through the partnership, TMC will also develop a Global Innovators Launch Pad to foster U.S. market entry for international health care companies. Founders will be selected to participate in the 10-week program at the TMC Innovation Factory in Houston.

“Gene and cell therapies are driving biotech innovation, opening possibilities for treating diseases once thought untreatable," William McKeon, president and CEO of the Texas Medical Center, said in a news release. "Expanding biomanufacturing capacity is essential to delivering the next wave of these therapies, and partnerships with leading innovators will strengthen our efforts in Houston and internationally.”

McKeon officially signed the TMC Korea BioBridge Memorandum of Understanding with Myoung Su Lee, chairman of KBIOHealth, in South Korea in October.

"This collaboration marks a significant milestone for Korea’s biohealth ecosystem, creating a powerful bridge between Osong and Houston," Lee added in the release. "By combining KBIOHealth’s strength in research infrastructure and Korea’s biotech talent with TMC’s global network and accelerator platform, we aim to accelerate innovation and bring transformative solutions to patients worldwide.”

This is the seventh international strategic partnership for the TMC. It launched its first BioBridge with the Health Informatics Society of Australia in 2016. It launched its TMC Japan BioBridge, focused on advancing cancer treatments, last year. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.